Keywords
cisplatin
controlled release
optical visualization
PDT
platinum(IV) prodrug
riboflavin
Abstract
Novel triple-action photoactivatable PtIV prodrugs were obtained by modification of Riboplatin, a cisplatin-based prodrug bearing tetraacetylriboflavin in axial position. The modification involved incorporation of either Naproxen or albumin vector maleimide residues onto the second axial position of Riboplatin. The PtIV prodrugs thus obtained possess improved pharmacokinetic, biological and photoactivating properties.
Funders
Russian Science Foundation
22-15-00182
References
1.
Spector D., Krasnovskaya O., Pavlov K., Erofeev A., Gorelkin P., Beloglazkina E., Majouga A.
International Journal of Molecular Sciences,
2021
2.
Jin S., Muhammad N., Sun Y., Tan Y., Yuan H., Song D., Guo Z., Wang X.
Angewandte Chemie - International Edition,
2020
3.
Wang Z., Wang N., Cheng S., Xu K., Deng Z., Chen S., Xu Z., Xie K., Tse M., Shi P., Hirao H., Ko C., Zhu G.
Chem,
2019
4.
Larsen M.T., Kuhlmann M., Hvam M.L., Howard K.A.
Molecular and Cellular Therapies,
2016
5.
Xu Z., Wang Z., Deng Z., Zhu G.
Coordination Chemistry Reviews,
2021
6.
Muhammad N., Sadia N., Zhu C., Luo C., Guo Z., Wang X.
Chemical Communications,
2017
7.
Wilson J.J., Lippard S.J.
Inorganic Chemistry,
2011
8.
Rottenberg S., Disler C., Perego P.
Nature Reviews Cancer,
2020
9.
Kastner A., Poetsch I., Mayr J., Burda J.V., Roller A., Heffeter P., Keppler B.K., Kowol C.R.
Angewandte Chemie - International Edition,
2019
10.
Fronik P., Poetsch I., Kastner A., Mendrina T., Hager S., Hohenwallner K., Schueffl H., Herndler-Brandstetter D., Koellensperger G., Rampler E., Kopecka J., Riganti C., Berger W., Keppler B.K., Heffeter P., et. al.
Journal of Medicinal Chemistry,
2021
11.
Pham T.C., Nguyen V., Choi Y., Lee S., Yoon J.
Chemical Reviews,
2021
12.
Bareford L.M., Phelps M.A., Foraker A.B., Swaan P.W.
Molecular Pharmaceutics,
2008
13.
Xu Z., Chan H.M., Li C., Wang Z., Tse M., Tong Z., Zhu G.
Inorganic Chemistry,
2018
14.
Huang J., Ding W., Zhu X., Li B., Zeng F., Wu K., Wu X., Wang F.
Frontiers in Chemistry,
2022
15.
Pang L.Y., Hurst E.A., Argyle D.J.
Stem Cells International,
2016
16.
Spector D., Pavlov K., Beloglazkina E., Krasnovskaya O.
International Journal of Molecular Sciences,
2022
17.
Feng G., Zhou X., Chen J., Li D., Chen L.
Frontiers in Oncology,
2023
18.
Krasnovskaya O.O., Akasov R.A., Spector D.V., Pavlov K.G., Bubley A.A., Kuzmin V.A., Kostyukov A.A., Khaydukov E.V., Lopatukhina E.V., Semkina A.S., Vlasova K.Y., Sypalov S.A., Erofeev A.S., Gorelkin P.V., Vaneev A.N., et. al.
ACS applied materials & interfaces,
2023
19.
Li J., Valkenburgh J.V., Fang J., Zhang D., Chen Y., Chen Q., Jia G., Chen A.Z., Zhang X., Chen K.
Pharmacological Research,
2022
20.
Deng Z., Zhu G.
Current Opinion in Chemical Biology,
2023
21.
Zhong T., Yu J., Pan Y., Zhang N., Qi Y., Huang Y.
Advanced healthcare materials,
2023
22.
Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action
Spector Daniil V., Bubley Anna A., Beloglazkina Elena K., Krasnovskaya Olga O.
Russian Chemical Reviews,
2023
23.
Shi Z., Luo M., Huang Q., Ding C., Wang W., Wu Y., Luo J., Lin C., Chen T., Zeng X., Mei L., Zhao Y., Chen H.
Nature Communications,
2023
24.
Kurmaz S.V., Ulyanov I.V., Emelyanova N.S., Kurmaz V.A., Kozlov A.V., Sizov L.R., Rybkin A.Y.
Mendeleev Communications,
2024
25.
Spector Daniil, Abramchuk D. S., Bykusov V. V., Zharova A. O., Egorova E. S., Voskresenskaya A. S., Olovyanishnikov A. R., Kuzmichev I. A., Bubley A. A., Antipin R. L., Beloglazkina Elena, Krasnovskaya Olga
Russian Chemical Reviews,
2024
26.
Bortnevskaya Y.S., Malikova V.A., Karpechenko N.Y., Bragina N.A., Zhdanova K.A.
Mendeleev Communications,
2024